Kendle further expands Asia-Pacific presence

By Staff reporter

- Last updated on GMT

Related tags: Pharmacology, Pharmaceutical industry

US CRO Kendle has set up three units in Malaysia, Thailand and the Philippines, further demonstrating the growing importance of the Asia Pacific for the contract research sector.

The new offices, which are in Kuala Lumpur, Bangkok and Manila, will focus on providing contract research services for the region’s biopharmaceutical development and manufacturing sector.

Ross Horsburgh, vice president of Kendle’s global clinical development operations explained that: “With more than half of the world’s population, Asia offers an abundance of patients in nearly every therapeutic area.”

He went on to say that: “Governments have highlighted biopharmaceutical development as a key pillar to their economies, resulting in much more favourable environments for global clinical development work​.”

According a recent study by the Tufts Center for the Study of Drug Development 65 per cent of all US Food and Drug Administration (FDA) regulated trials will take place outside the US, with a significant proportion being carried out in Asia.

Recognition of this trend coupled with an increasing awareness of the importance of local knowledge has seen a number of US contract research organisations (CRO), most recently Covance and PRA, invest in the region.

Cost of trials

While the potential of the Asian trial market is clearly a motivation for Kendle building its presence in the region, the cost savings provided by the region are also a factor.

In Q1, the firm reported a 45 per cent project cancellation rate, cut its 2009 earnings expectations and said that it was examining ways of reducing costs, including expanding it network in Asia.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us


View more